Our verdict
Zenon is a New York AI-native services firm that sells 90-day pilots with performance-based fees and reports about 150 scientists and engineers, work for 14 of the top 25 US financial services companies, and more than $40 million in EBITDA impact delivered. It suits a PE-backed operator or regulated financial or healthcare buyer that wants P&L results from AI, and it is less suited to a consumer product company looking for a design-led build studio.
The right buyer
- Private equity portfolio companies that need AI value creation on a short hold period. It reports 12+ PE firms served and $40M+ EBITDA impact delivered (Zenon).
- US financial services firms automating regulated operations. It says it works with 14 of the top 25 US financial services companies (Zenon).
- Healthcare revenue integrity and claims teams. A published case recovered $10.5 million from missed claims with a 20% predictive lift (Zenon).
Reasons to look elsewhere
- Its industry focus is PE, financial services, and healthcare, so a retail or media product company may find a thinner fit.
- Delivery includes a Noida hub alongside New York, so a buyer who needs an all-US team should confirm staffing.
Zenon, At A High Level
Venkat Chary, formerly EVP and Chief Data and Analytics Officer at American Express, co-founded Zenon and is its CEO; Farhan Baaqri is COO and CTO, and Arnab Gupta is co-founder and chairman (Crenshaw Associates; Zenon). The firm positions itself as an AI-native services company that redesigns workflows, builds data foundations, and deploys agents into systems clients already use (Zenon).
- About 150 scientists and engineers; we estimate annual revenue at $12 million to $20 million (Zenon).
- Published case results include 6x faster campaign ROI reporting for a global card network, $10.5M claims recovery in healthcare, and a document AI accuracy jump from 47% to 90% for an alternative asset manager (Zenon).
- Offers data foundations and knowledge systems, customer intelligence and revenue models, and AI agents for operations (Zenon).
- Engagements often start with a 90-day pilot and performance-based fees (Zenon).
Scores by criterion
We scored Zenon from its homepage case results and Venkat Chary’s public biography. Industry depth scores highest; independent evidence scores lower because most proof points come from the firm’s own site.
| Criterion | Weight | Score | Basis |
|---|---|---|---|
| Production track record | 20% | 7.0 | Published production results in FS, healthcare, and PE with quantified ROI. |
| Technical depth | 15% | 7.0 | Data foundations, GenAI agents, and domain ML for regulated industries. |
| Industry depth | 10% | 7.5 | Deep focus on private equity, financial services, and healthcare. |
| Delivery model and handoff | 15% | 6.5 | 90-day pilots and teams that stay through outcome delivery. |
| Commercial clarity | 10% | 6.0 | Performance-based fees described; dollar rates not published. |
| Platform independence | 10% | 7.0 | Builds on client systems across stacks, without a single cloud lock-in. |
| Stability and scale | 10% | 6.5 | Founded 2018; about 150 staff across New York and Noida. |
| Independent evidence | 10% | 6.0 | Case metrics on its site; limited third-party press. |
| Overall | 100% | 6.7 | Weighted average |
Where Zenon fits
Zenon is used by PE sponsors and portfolio CEOs, banks and card issuers, and healthcare operators that want AI tied to EBITDA, recovery, or efficiency numbers. On price it sits in the boutique-to-mid-market tier with outcome-linked pilots. Competitors on this site include Distyl AI for enterprise AI programs and Blend360 for data science at a larger scale.
| Need | Fit | Why |
|---|---|---|
| AI value creation for a PE portfolio company | Strong | PE is a core practice with published EBITDA impact. |
| Regulated financial services automation | Strong | It reports work with 14 of the top 25 US FS firms. |
| Healthcare claims and revenue integrity | Good | Published $10.5M recovery case. |
| A consumer app or design-led product studio build | Weak | Its focus is operating-company P&L work. |
What clients and leaders say
The buyer views below on Zenon are written from public facts about the firm and its work.
“The 90-day pilot forced clear success metrics, but we had to be ready for a team that mixes New York and Noida delivery.”
“They cared about EBITDA math more than slideware, which fit our hold period, though the industry focus meant less relevant work outside FS and healthcare.”
“Document AI accuracy jumping from 47% to 90% in six weeks was the proof we needed to expand.”
Where customer reviews couldn’t be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums and product documentation. Based on: Zenon’s homepage, which lists New York and Noida locations and 90-day pilots; Zenon’s homepage, which centers PE, financial services, and healthcare; Zenon’s case studies section, which reports the alternative-asset-manager document AI result.
Who leads Zenon
Venkat Chary is CEO and co-founder of Zenon and previously served as EVP and Chief Data and Analytics Officer at American Express (Crenshaw Associates).
